Product market

The initial application for the Mobi-Drip Fluid Infusion Device is in the area of home healthcare, where there is a clear market demand for a simple infusion device that requires no technical training for its use.

There is a growing trend worldwide toward shorter hospital stays and an increased emphasis on alternate care sites, such as home healthcare. With spiralling costs to run and service hospitals, there is an absolute cost advantage to governments where Patients can be treated in their own homes. The inherent cost savings offered by home healthcare have lead to a major worldwide shift towards products, services and therapies that are focused upon the home care market. In particular there is an increasing demand for home-based infusion services that allow the patient to remain mobile during treatment. One example is the regular requirement for Intravenous drug therapy for:

• Pain management following major surgery, following traumatic injuries, pain associated with to terminal cancer.
• Chemotherapy for the treatment of disease such as HIV/AIDS, cancers, lymphomas
• Antibiotic/Anti-Infective therapy for urinary tract infections, sepsis, osteomyelitis, would infections, cellulitis,
• Hydration for HIV/AIDS, cancer, hyperemesis (including during pregnancy)

Already the US market for Home Intravenous Therapy is in the Billions of dollars and like Australia, growing at an ever increasing rate.